A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors

Journal of Medicinal Chemistry
1984.0

Abstract

A common three-dimensional receptor model has been formulated for six different classes of rat liver dihydrofolate reductase inhibits using the distance geometry approach. Altogether, 62 molecules of five different classes were used to generate the receptor model, which has 11 attractive site points and 5 repulsive ones. It gave a fit having a correlation coefficient of 0.949 and root mean square (rms) deviation of 0.527. The attractive site points of the model closely correspond to the one we reported earlier. The model successfully predicted the biological data of 33 molecules of 5 different classes, one molecule of which was a member of a new class not included in the original data set. Guidelines are put forth for the synthesis of improved inhibitors.

Knowledge Graph

Similar Paper

A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1984.0
Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines
Journal of Medicinal Chemistry 1983.0
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1985.0
Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogs
Journal of Medicinal Chemistry 1985.0
Three-Dimensional Quantitative Structure−Activity Relationship Analysis of a Set ofPlasmodium falciparumDihydrofolate Reductase Inhibitors Using a Pharmacophore Generation Approach
Journal of Medicinal Chemistry 2004.0
Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens
Bioorganic & Medicinal Chemistry 2010.0
Validation of EGSITE2, a Mixed Integer Program for Deducing Objective Site Models from Experimental Binding Data
Journal of Medicinal Chemistry 1997.0
Solution of the Conformation and Alignment Tensors for the Binding of Trimethoprim and Its Analogs to Dihydrofolate Reductase:  3D-Quantitative Structure−Activity Relationship Study Using Molecular Shape Analysis, 3-Way Partial Least-Squares Regression, and 3-Way Factor Analysis
Journal of Medicinal Chemistry 1996.0
Computational Predictions of Binding Affinities to Dihydrofolate Reductase:  Synthesis and Biological Evaluation of Methotrexate Analogues
Journal of Medicinal Chemistry 2000.0
Receptor-based design of novel dihydrofolate reductase inhibitors: benzimidazole and indole derivatives
Journal of Medicinal Chemistry 1991.0